Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

Satoru Taguchi; Haruki Kume; Taketo Kawai; Yukari Uemura; Daisuke Yamada; Jun Kamei; Keigo Sato; Mariko Tabata; Satoru Takahashi; Tappei Takada; Michio Noda; Katsuhiko Nara; Hiroaki Nishimatsu; Yutaka Enomoto; Kazuma Sugimoto; Yusuke Sato; Tomoyuki Kaneko; Jimpei Miyakawa; Kenjiro Kishitani; Daisuke Obinata; Takehiro Tanaka; Hiroshi Fukuhara; Kenya Yamaguchi; Yuta Yamada; Yukio Yamada; Hideyo Miyazaki; Yoshiyuki Akiyama; H Hoshina; Tohru Nakagawa; Tetsuya Fujimura; Yu Nakamura; Yoshitsune Furuya; Sayuri Takahashi; Y. Ambe; Yume Adachi; Aya Niimi; Yujiro Sato; Shigenori Kakutani

doi:10.21203/rs.3.rs-4620148/v1

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

Satoru Taguchi(Iwate Medical University), Haruki Kume(The University of Tokyo), Taketo Kawai(National Center for Global Health and Medicine), Yukari Uemura(University of Tokyo Hospital), Daisuke Yamada(International Research Center for Japanese Studies), Jun Kamei(The University of Tokyo), Keigo Sato(Meiji University), Mariko Tabata(The University of Tokyo), Satoru Takahashi(Nihon University), Tappei Takada(University of Tokyo Hospital), Michio Noda(Teikyo University), Katsuhiko Nara(University of Tokyo Hospital), Hiroaki Nishimatsu(Memorial Hospital of South Bend), Yutaka Enomoto(Mitsui Memorial Hospital), Kazuma Sugimoto(National Center for Global Health and Medicine), Yusuke Sato(Tokai University), Tomoyuki Kaneko(Teikyo University), Jimpei Miyakawa(Kyorin University), Kenjiro Kishitani(The University of Tokyo), Daisuke Obinata(Nihon University), Takehiro Tanaka(Okayama University), Hiroshi Fukuhara(Kyorin University), Kenya Yamaguchi(Nihon University), Yuta Yamada(Yamagata University), Yukio Yamada(Musashino Red Cross Hospital), Hideyo Miyazaki(National Center for Global Health and Medicine), Yoshiyuki Akiyama(Tokyo Medical and Dental University), H Hoshina(Jichi Medical University), Tohru Nakagawa(Sapporo Kosei General Hospital), Tetsuya Fujimura(Jichi Medical University), Yu Nakamura(Kyorin University), Yoshitsune Furuya, Sayuri Takahashi(Tokyo Medical University), Y. Ambe(The University of Tokyo), Yume Adachi(Musashino Red Cross Hospital), Aya Niimi(The University of Tokyo), Yujiro Sato(The University of Tokyo), Shigenori Kakutani(The University of Tokyo)

Research Square

July 18, 2024

10.21203/rs.3.rs-4620148/v1

Cited by 2

Related Papers

Decreased extra-renal urate excretion is a common cause of hyperuricemia

|Nature Communications|2012|703

Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

|PubMed|1997|466

Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population

|Science Translational Medicine|2009|438

Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation

|Blood|2017|352

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes

|Annals of the Rheumatic Diseases|2015|185